In clinical practice, the commonly utilized bone-turnover markers in CKD are BAP and iPTH; however, we used TRACP-5b as a specific biomarker of osteoclast number and activity, as it is not influenced by renal function and its level was reported to be correlated with most histomorphometric and histodynamic parameters [19]. Here, ACP5 is linked to chronic kidney disease.